Metformin alters upper small intestinal microbiota that impact a glucose-Sglt1-sensing Glucoregulatory pathway
Este artculo, basado en la revisin publicada en Endocrinology (2024) por Mateus Dvila et al., ofrece una mirada crtica sobre estos agentes desde la fisiologa del hambre y su integracin neuroendocrina
That has now changed
The tiredness typically resolves while weight loss continues
"For people with type 2 diabetes who are at the point in their treatment journey where they would progress to an injectable therapy, these positive results emphasize tirzepatide's potential to deliver a meaningful impact in lowering their A1C and weight," said Bernhard Ludvik, M.D., Associate Professor of Medicine, Landstrasse Clinic, Vienna, and Principal Investigator of SURPASS-3
This mechanism improves blood sugar control, reduces appetite, and leads to weight loss